"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...

The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...

Jim Jones, the head of the Food and Drug Administration’s (FDA) food division, resigned Monday, citing the mass firings of ...

The Trump administration firings of employees at the U.S. Food and Drug Administration caused FDA Deputy Commissioner for ...

Signage is seen in 2020 outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland. Journavx is a non-opioid oral medication used for some types of acute pain ...

Plans for a drugs, alcohol and mental health therapy centre on the site of the former Nottinghamshire Fire and Rescue Service headquarters have been tipped for approval. The site in Bestwood Lodge ...

Amgen Inc.’s disclosed that US regulators paused the study of an early-stage obesity drug, a lucrative market the company is trying to crack. The Thousand Oaks, California-based drugmaker didn ...

Staffers of the U.S. Agency for International Development were instructed to stay out of the agency’s Washington headquarters on Monday, according to a notice distributed to them, after ...

FDA was able to recruit new talent by not restricting hiring to only regions where FDA offices were located and, regardless of how FDA and these employees comply with the requirements of this ...

A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous Brenton Blanchet is a writer-reporter at PEOPLE. He has been working at PEOPLE ...

On Thursday, Jan. 30, The U.S. Food and Drug Administration announced that it has approved a new non-opioid painkiller pill from Vertex Pharmaceuticals called suzetrigine, which is being sold under ...